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Summary
Several mitochondrial proteins are tumor suppressors. These include succinate dehydrogenase (SDH) and fumarate hydra-
tase, both enzymes of the tricarboxylic acid (TCA) cycle. However, to date, the mechanisms by which defects in the TCA
cycle contribute to tumor formation have not been elucidated. Here we describe a mitochondrion-to-cytosol signaling
pathway that links mitochondrial dysfunction to oncogenic events: succinate, which accumulates as a result of SDH
inhibition, inhibits HIF- prolyl hydroxylases in the cytosol, leading to stabilization and activation of HIF-1. These results
suggest a mechanistic link between SDH mutations and HIF-1 induction, providing an explanation for the highly vascular
tumors that develop in the absence of VHL mutations.
Introduction mutations promotes metastasis by inducing the expression of
met and CXCR4 (Pennacchietti et al., 2003; Staller et al., 2003).
Inherited or somatic mutations in subunits B, C, or D of the The VHL gene product (pVHL) is part of an E3 ubiquitin ligase
SDH genes are associated with the development of pheochro- complex that binds to the oxygen-dependent degradation
mocytoma and paraganglioma (Baysal, 2003; Eng et al., 2003; (ODD) domain of HIF- in an oxygen-dependent manner and
Pollard et al., 2003; Rustin and Rotig, 2002). More recently, targets it for degradation (Pugh and Ratcliffe, 2003; Semenza,
SDHBmutations have also been associatedwith renal cell carci- 2002). Therefore, in tumors carrying VHL mutations that can no
noma and papillary thyroid cancer (Neumann et al., 2004), and longer bind to and destabilize HIF-1, HIF-1 is stabilized even
downregulation of SDHD was reported in gastric and colon under normoxic conditions (Kaelin, 2002).
carcinoma (Habano et al., 2003). Furthermore, mutations inSDH The binding of pVHL to HIF- is regulated by the hydroxyla-
were shown to induce the hypoxia-response pathway in tumors tion of two specific prolyl residues in the ODD domain (Ivan et
(Baysal, 2003; Pollard et al., 2003). In particular, elevated levels al., 2001; Jaakkola et al., 2001; Yu et al., 2001). Hydroxylation
at the 4-position of Pro-402 and Pro-564 of HIF- (numbers referof hypoxia inducible factor-1 (HIF-1) in nuclei and the induc-
tion of hypoxia-inducible genes were observed in paragangli- to human HIF-1) enables formation of two hydrogen bonds to
pVHL and increases the binding of pVHL to HIF- by severaloma carrying an SDHD mutation (Gimenez-Roqueplo et al.,
2001). HIF- subunit is the oxygen-inducible component of the orders of magnitude (Hon et al., 2002; Min et al., 2002). This
posttranslational modification is catalyzed by the HIF--prolylHIF transcription factor, a heterodimer comprised of HIF- and
HIF- subunits (Pugh and Ratcliffe, 2003; Semenza, 2002). The hydroxylases (HPH1-3 or PHD1-3) (Bruick and McKnight, 2001;
Epstein et al., 2001; Ivan et al., 2002). PHD activity is dependentphysiological function of HIF is to promote adaptation of cells
to low oxygen by inducing neovascularization and glycolysis on molecular oxygen and is considered to be an important
oxygen sensing mechanism in animal cells (Safran and Kaelin,(Pugh and Ratcliffe, 2003; Semenza, 2002). In addition, it was
recently demonstrated that HIF activation resulting from VHL 2003; Schofield and Ratcliffe, 2004). In addition to oxygen, the
S I G N I F I C A N C E
Succinate dehydrogenase (SDH) is a mitochondrial TCA cycle enzyme and a tumor suppressor. Inherited or somatic mutations in
subunits B, C, or D of SDH lead to pheochromocytoma, paraganglioma, or renal cell carcinoma, and SDH downregulation is observed
in gastric and colon carcinoma. No mechanism that links these mutations to tumor formation has been reported previously. In this
study we show that succinate, a TCA cycle metabolite, is accumulated due to SDH downregulation and transmits an “oncogenic”
signal from mitochondria to the cytosol. Once in the cytosol, succinate inhibits HIF- prolyl hydroxylase (PHD) leading to HIF-1
stabilization under normoxic conditions. Thus, succinate can increase expression of genes that facilitate angiogenesis, metastasis,
and glycolysis, ultimately leading to tumor progression.
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PHDs utilize -ketoglutarate as a cosubstrate and require fer-
rous iron (Fe2) and ascorbate as cofactors (Kaelin, 2002; Scho-
field and Zhang, 1999). The PHD isozymes belong to the Fe2
and-ketoglutarate-dependent family of dioxygenases that split
molecular oxygen to hydroxylate their substrates and, in parallel,
oxidize and decarboxylate -ketoglutarate to succinate (Scho-
field and Zhang, 1999). The transcriptional activity of HIF- is
also regulated by hydroxylation of an asparaginyl residue in its
C-terminal transactivation domain in a reaction catalyzed by
factor inhibiting HIF (FIH) (Hewitson et al., 2002; Lando et al.,
2002a, 2002b). Significantly, both-ketoglutarate and succinate
are TCA cycle intermediates; in the TCA cycle, succinate is
converted to fumarate bySDH. Furthermore, succinate has been
shown to inhibit some -ketoglutarate-dependent oxygenases,
including procollagenprolyl hydroxylase and thymine-7-hydrox-
ylase (Holme, 1975; Myllyla et al., 1977). Succinate moves freely
between the mitochondria and the cytosol via the dicarboxylic
acid translocator in the mitochondrial inner membrane and the
voltage-dependent anion channel (VDAC/porin) in themitochon-
drial outer membrane. In this paper, we show that downregula-
tion of SDH activity results in the accumulation of succinate
in cells, which inhibits HIF- hydroxylases (product inhibition),
leading to the dissociation of pVHL from HIF-1 and conse-
Figure 1. Inhibition of SDH activity increases HIF-1 levels and HIF activityquently leading toHIF-1 stabilization and overall HIF activation.
A:Cells were transfected (in triplicate) with either scrambled siRNA (scRNAi)We suggest that succinate can act as an intracellular messen-
or siRNAdirected at SDHD subunit (Di3 or Di4). Following transfections, mRNAger, linking TCA cycle dysfunction to HIF regulation.
levels of endogenous SDHD and actin were quantified by RT-PCR.
B: Succinate-DCIP oxidoreductaseactivity was analyzed in cells transfected
Results as in A to confirm inhibition of SDH activity.
C: Endogenous HIF-1 and BNIP3 protein levels, under normoxic conditions,
were detected by Western blot analysis following transfection with scRNAi,Inhibition of SDH in cells using siRNA leads to HIF-1
Di3, or Di4. Actin was used as loading control.accumulation and the induction of HIF
D: HIF transcriptional activity following SDH inhibition (as in C) was assessed
transcription activity by the dual luciferase reporter assay system (Promega) using pGL2/HRE-
To study the mechanism that links SDH inhibition to HIF-1 luciferase as a reporter for HIF activity.
induction, the RNA interference (RNAi) technique was used to
transiently target SDH in cells. Vectors encoding small interfer-
ence RNA (siRNA) that target the SDHD subunit (Di3 or Di4)
were constructed, and their function was analyzed by transfec- Moreover, when HIF activity was analyzed by cotransfection of
tion into human embryonic kidney cells (HEK293). Transfection a vector containing luciferase reporter gene downstream to a
efficiency was analyzed by cotransfecting the cell population minimal promoter with a hypoxia responsive element (HRE), a
with a GFP-encoding vector and was 50% in all experiments 3-fold induction in HIF activity was observed in the SDH-inhib-
described below (data not shown). Endogenous SDHD mRNA ited cell population (Figure 1D). BNIP3 is a proapoptotic Bcl-2
levels were analyzed by RT-PCR and found to be lower in cells family member that was shown to be induced in a HIF-depen-
transfected with either of the two SDHD siRNA constructs (Di3 dent manner in hypoxic zones of tumors (Sowter et al., 2001).
or Di4) as compared to scrambled siRNA (scRNAi) control-trans- Analysis of the endogenous level of BNIP3 showed a marked
fected cells (Figure 1A), demonstrating the effectiveness of Di3 induction of BNIP3 protein in SDH inhibited cells as compared
and Di4. To analyze the efficacy of siRNA at inhibiting endoge- to control-transfected cells (Figure 1C).
nous SDHactivity, succinate and 2,6-dichloroindophenol (DCIP)
Next, we compared HIF-1 protein levels in SDH-inhibited
were used as electron donor and acceptor, respectively, to
cells under normoxic conditions to HIF-1 physiological levelsspectrophotometrically measure SDH activity (Trounce et al.,
under hypoxic conditions. Cells were transfected with either1996). When cells were transfected with either Di3 or Di4, SDH
scRNAi or Di3 under normoxic conditions, or incubated at 3%activity was decreased by 50% in the total cell population,
oxygen or treated with CoCl2, an inhibitor of PHD and a hypoxicas compared to scRNAi-transfected cells (Figure 1B). This sug-
mimetic compound (Safran and Kaelin, 2003), for 3 hr. Hypoxiagests that SDHactivity in transfected cells is severely diminished
or hypoxic mimetic treatment induced higher levels of HIF-1at the time of analysis. Transfection of any of the siRNAs had no
than SDH inhibition (Figure 2A, upper panel). However, it iseffect on citrate synthase activity, an unrelated nuclear-encoded
important to note that while all cells experienced hypoxic condi-TCA cycle enzyme (data not shown). Since elevated levels of
tions, only the transfected cells have reduced SDH activity.HIF-1 protein are observed in tumors harboring SDH muta-
When the expression of an endogenous HIF target gene, VEGF,tions, the effect of SDH inhibition on HIF-1 protein levels was
was analyzed, a clear induction in VEGF mRNA levels was ob-analyzed by Western blot. An induction of HIF-1 protein under
served in the population of Di3-transfected cells (Figure 2B).normoxic conditions was observed in Di3- and Di4-transfected
cells as compared to the control-transfected cells (Figure 1C). Allowing for the transfection efficiency of the culture, the level
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Reactive oxygen species do not play a role in HIF-1
induction after SDH inhibition
One possible explanation for the stabilization of HIF-1 in SDH-
inhibited cells is the generation of reactive oxygen species (ROS)
(Baysal, 2003; Eng et al., 2003; Pollard et al., 2003; Rustin
and Rotig, 2002). To test this hypothesis, we analyzed ROS
generation in siRNA-transfected cells using dihydroethidium
(DHE), a fluorescent probe for superoxide. The tumor suppres-
sor p53, which is known to elevate ROS production (Polyak et
al., 1997), was used as a positive control. While there was a
pronounced increase in ROS level following transfection with a
p53-encoding plasmid as compared to control-transfected cells
(Figures 3A and 3B), there was no detectable difference in DHE
oxidation in Di3 and Di4-transfected cells relative to the control
(compare Figures 3C and 3D to 3A). In addition, we examined
siRNA-transfected cells for evidence of ROS formation and oxi-
dative stress by measuring the levels of reduced glutathione
(GSH) and total glutathione (GSH  GSSG). In agreement with
the DHE results, no significant difference was observed in the
redox state of SDH-inhibited cells as compared to the control
scRNAi-transfected cells (Table 1).
Succinate is accumulated in SDH-inhibited cells
An alternative explanation for the induction of HIF-1 in SDH-
deficient cells is the accumulation of succinate, the substrate
for SDH in mitochondria and a product of PHD in the cytosol.
Succinate can move freely between mitochondria and the cyto-
sol via the dicarboxylic acid translocator in the mitochondrial
inner membrane and VDAC in the mitochondrial outer mem-
brane. Once in the cytosol, succinate may impede PHD activity
Figure 2. HIF-1 and HIF-2 induction in SDH inhibited or hypoxic cells by inhibiting the decarboxylation of -ketoglutarate to succi-
nate, a required coreaction for PHD while hydroxylating itsA: Protein levels of HIF-1 and HIF-2 in cells transfected with either control
scRNAi or siRNAdirectedat SDHD subunit (Di3), or in cells exposed to hypoxic target.
conditions (3% oxygen; 3 hr Hyp) or to the hypoxic mimetic (CoCl2). Actin To determine if SDH inhibition led to an accumulation of
protein level was used as loading control.
succinate, gas chromatography-mass spectrometry (GCMS)B:mRNA levels (analyzed by RT-PCR) of VEGF or actin in cells treated as inA.
was used tomeasure succinate levels in cells following transfec-The two distinct products of VEGF cDNA are most likely due to alternatively
spliced forms of the VEGF mRNA. tion with the indicated siRNA. The amount of succinic acid in
cell extracts was calculated by comparison to a known amount
of deuterated (D4)-succinic acid used as a reference in the lysis
solution (Figure 4). When cells were transfected with either ofof VEGF mRNA in Di3-transfected cells is comparable to that
the SDHD-targeting siRNAs, an increase in succinic acid levelin cells exposed to hypoxic conditions or CoCl2 (Figure 2B). was observed as compared to control-transfected cells (seeHIF transcriptional activity is regulated by the levels of both
Figure 4 for Di3). The concentration of succinate in the trans-HIF-1 andHIF-2, which heterodimerize with theHIF- subunit
fected cells was then estimated based on 50% transfectionand induce the transcription of genes containing HREs in their
efficiency as judged by cotransfection with GFP and the meanpromoter/enhancer region. However, the regulation of HIF-1
cell volume measured by Coulter counter prior to extraction. Aand HIF-2 expression is not necessarily similar in tumors
significant increase in succinate levels was observed in SDH-(Beasley et al., 2002) or during physiological response to hyp-
inhibited cells (Table 1). It is noteworthy that in contrast tooxia or hypoglycemia (Brusselmans et al., 2001). For this reason,
succinate, the basal level of -ketoglutarate was estimated toHIF-2 induction was also analyzed in SDH-inhibited cells. Al-
be 50 M, with no significant change after SDH inhibitionthough there was a noticeable increase in HIF-2 protein in Di3-
(data not shown).transfected cells, this increase was not as pronounced as that
of HIF-1 (Figure 2A). Moreover, when cells were exposed to
Succinate inhibits PHD activity in vitrohypoxia or hypoxic mimetic conditions, it was evident that HIF-
To test the hypothesis that the elevated succinate level may1 is more subject to induction than HIF-2 (Figure 2A). This
inhibit PHD by product inhibition, PHD activity was analyzedobservation may be explained by the fact that different PHD
in vitro in the presence of increasing amounts of succinateenzymes, i.e., PHD2 and PHD3, differentially regulate the stabil-
(Figure 5A). In vitro translated HA-tagged ODD domain wasity of HIF-1 and HIF-2, respectively (Appelhoff et al., 2004),
used as a substrate, and cell extracts were used as a source ofand these enzymes may exhibit differences in their response to
PHDactivity.When theHA-ODD is incubatedwith cell extracts insuccinate and/or hypoxia. Alternatively, other mechanisms may
the presence of physiological levels of -ketoglutarate, Fe2,facilitate HIF-2 degradation in these cells, despite the fact that
PHD activity is inhibited. and ascorbate, it undergoes hydroxylation and migrates faster
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Figure 3. Inhibition of SDH activity has no effect
on ROS production
A–D: Microscopic analysis of DHE oxidation in
cells transfected with either scRNAi control (A),
p53, as a positive control (B), or siRNA directed
at SDHD subunit Di3 (C) or Di4 (D).
on SDS-PAGE (Huang et al., 2002; Ivan et al., 2001). Deferoxa- pattern of expression in SDH-deficient tumors (Gimenez-
mine (DFO) is an iron chelator that inhibits PHD activity and can Roqueplo et al., 2001).
therefore be used as a hypoxia mimetic agent to stabilize HIF- Next, it was determined whether elevated succinate levels
levels in certain cells (Safran and Kaelin, 2003). DFO inhibited following SDH inhibition decreased PHD activity in cells. A GFP-
PHD activity in vitro and retarded HA-ODD mobility on SDS- ODD domain fusion protein was used, the degradation of which
PAGE (Figure 5A, lane 6). Importantly, increasing amounts of is enhanced by pVHL overexpression (Figure 6Aiii and 6Aiv) and
succinate in the hydroxylation reaction led to a dose-dependent
decrease in the production of the faster migrating, hydroxylated
HA-ODD (Figure 5A, lanes 1–5). The IC50 was 0.5 mM for
succinate under these reaction conditions, a level that is attain-
able in SDH-inhibited cells (Table 1).
Elevation of succinate level following downregulation
of SDH leads to PHD inhibition and HIF-1
stabilization in cells
To determine if high levels of succinate are sufficient to elevate
HIF-1 levels in cells, we incubated cells with the membrane-
permeable dimethyl-ester succinic acid derivative (DMS) and
analyzed for HIF-1 levels. Although the rates of DMS uptake,
its conversion into succinate, and its metabolism are unknown,
cells incubated with 20 mM DMS for 48 hr showed elevated
levels of HIF-1 under normoxic conditions (Figure 5B). More-
over, a clear accumulation of HIF-1 in the nuclei of cells treated
with DMS was observed (Figure 5C), resembling the HIF-1
Table 1. Effects of SDH inhibition on cellular redox state and succinate con-
centration
scRNAi Di3 Di4
GSH (nmol/mg) 44.0  5.03 42.3  9.76 46.3  1.05
GSH  GSSG 45.9  5.13 44.2  9.80 48.7  0.82
Figure 4. SDH inhibition leads to increased levels of succinateSuccinate (M) 120.6  32.0 446.8  86.1 440.9  36.0
GCMS profiles of selected ionized fragments in extracts from cells trans-The levels of reduced (GSH) and total (GSHGSSG) glutathione presented
fected with either scRNAi (A) or Di3 (B). Deuterated (D4)-succinic acid wasas nmol/mg protein and the level of succinate (M) in cells transfected with
used as a reference and was identified by its major ion component of 119the indicated siRNA. Results are average  SD of three or six independent
amu at retention time of 8.05 min. Succinic acid was identified by its majortransfections for glutathione or succinate, respectively.
ion component of 115 amu at retention time of 8.15 min.
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Figure 5. Succinate inhibits PHD activity in vitro
and induces HIF-1 levels in cells
A: Cell extracts were mixed with in vitro trans-
lated HA-ODD in the presence of Fe2, ascor-
bate, and -ketoglutarate. Where indicated,
succinate was added to the reaction. Deferoxa-
mine (DFO), an iron chelator, was added to in-
hibit PHD activity. The hydroxylated polypeptide
migrates faster on SDS-PAGE.
B: HIF-1 and actin levels were assessed byWest-
ern blot of extracts from either untreated cells or
from cells treated with DMS or CoCl2 for 48 hr
under normoxic conditions.
C: Immunostaining was performed to analyze
the subcellular localization of HIF-1 in DMS-
treated and untreated control cells.
therefore depends on hydroxylation of the ODD domain for levels in the transfected cells, since HA-pVHL was expressed
equally in each of the transfections (Figure 6B, lower panel).degradation, in contrast to GFP (Figures 6Ai and 6Aii). When
cells were cotransfected with GFP-ODD, HA-tagged pVHL, and Therefore, it is likely that in SDH-inhibited cells, the HIF-1ODD
domain is hydroxylated less efficiently, and consequently theeither of the siRNA constructs, higher GFP levels were observed
in Di3- and Di4-transfected cells compared to scRNAi-trans- binding of pVHL to GFP-ODD is reduced.
To test this possibility, cells were transfectedwith HA-pVHL,fected cells (Figures 6Aiv–6Avi). To quantify the differences in
GFP-ODD levels, cells were lysed, and the amounts of GFP- either scRNAi or Di3, and GFP-ODD or GFP (the latter used as
negative control). GFP fluorescence was analyzed in extractsODD in the extracts were determined by Western blot using an
anti-GFP antibody (Figure 6B, upper panel). The differences in prior to or after immunoprecipitation with an anti-HA antibody,
tomeasure both total andpVHL-boundGFP. Following stringentGFP-ODD levels could not be attributed to differences in pVHL
Figure 6. Inhibition of SDH decreases PHDactivity
A: Cells were transfected with plasmids encod-
ing either GFP (i and ii) or GFP-ODD (iii–vi) without
pVHL (i, iii, v) or with pVHL (ii, iv, vi) together with
one of the indicated siRNA constructs: scRNAi
(i–iv), Di3 (v), or Di4 (vi). GFP fluorescence was
detected microscopically.
B: GFP-ODD and HA-pVHL protein levels in cells
transfected (in triplicate) as in Aiv–vi.
C: Cells were transfected with plasmids encod-
ing GFP or GFP-ODD together with HA-pVHL and
with the indicated siRNA. GFP fluorescence was
analyzed in cell extracts before and after immu-
noprecipitation with an anti-HA antibody. The
results are presented as the percent of GFP fluo-
rescence bound to HA-pVHL and are the aver-
age and standard deviation of three indepen-
dent transfections.
D: Direct detection of ODD domain hydroxyla-
tion by far Western blot analysis. Cells were trans-
fected (in triplicate) with plasmids encoding
GFP-ODD and the indicated siRNA (but without
HA-pVHL). Protein extracts were blotted onto ni-
trocellulose membrane and the binding of im-
munopurified HA-pVHL to the blotted GFP-ODD
proteinwas detected using ananti-HAantibody.
10 ng of the immunopurified HA-pVHL protein
was loaded on lane 10.
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washes, immunoprecipitated proteins were eluted using HA
peptide, and GFP fluorescence was analyzed (pVHL-bound
GFP) and compared to that of extracts prior to immunoprecipita-
tion (total GFP). Results are presented as percent pVHL-bound
GFP of total GFP (Figure 6C). Although GFP-transfected cells
have much higher total fluorescence than GFP-ODD-trans-
fected cells (Figures 6Aii and 6Aiv), pVHL-associated GFP fluo-
rescence was hardly detectable, demonstrating that in the GFP-
ODD transfected cells, pVHL-associated GFP fluorescence is
dependent on the ODD domain. In Di3-transfected cells, even
though the total GFP-ODD level was higher than in scRNAi-
transfected cells (Figures 6Aiv and 6Av), the levels of pVHL-
associated fluorescence were significantly lower (Figure 6C).
Since pVHL binding to the ODD domain is dependent on PHD
activity (Kaelin, 2002; Safran and Kaelin, 2003), these results
indicate that inhibiting SDH activity in cells results in decreased
PHD activity. Figure 7. A schematic model that summarizes the role of succinate in the
Finally, cells were transfected with GFP-ODD and either mitochondrion-to-cytosol signaling pathway
scRNAi, Di3, or Di4 (but not with pVHL). The hydroxylation status Succinate accumulated in the mitochondria due to SDH inhibition is trans-
of GFP-ODD was determined by examining the binding of puri- ported to the cytosol. Elevated cytosolic succinate inhibits PHD and thereby
HIF- hydroxylation. Consequently, pVHL binding to HIF- is decreased, andfied HA-pVHL protein to GFP-ODD expressed in these cells by
elevated HIF activity induces expression of genes that facilitate angiogen-far Western blot. The nitrocellulose membrane was probed with
esis, metastasis, and metabolism, leading to more aggressive tumors.
purified HA-pVHL protein and GFP-ODD/HA-pVHL complexes
were detected by an anti-HA antibody (Figure 6D). HA-pVHL
binding to the GFP-ODD extracted from scRNAi-transfected
cells was observed (Figure 6D, lanes 1–3), but a large decrease more oxidized state following SDH inhibition (Figure 3 and Table
in HA-pVHL binding to GFP-ODD was evident in Di3- and Di4- 1). Structural and functional analysis of bacterial SDH complex
transfected cells (Figure 6D, lanes 4–9). These results suggest suggested a mechanism for ROS production at the FAD site
that in SDH-inhibited cells, PHD activity is reduced. (Yankovskaya et al., 2003). The study of Yankovskaya et al.
further indicated that the bacterial homolog fumarate reductase,
Discussion
which catalyzes the reverse reaction of SDH, is more likely to
produce ROS than SDH. SDH itself can work in reverse and
Our results provide evidence for a previously unidentified mech-
generate ROS under hypoxic conditions (Paddenberg et al.,
anism for regulating PHD activity and consequently HIF-1 lev-
2003), but such a reaction (and ROS generation) does not occurels. We describe a direct signaling pathway that links mitochon-
under normoxic conditions and is unlikely to be catalyzed bydrial dysfunction to tumorigenesis, providing a mechanistic link
mutated SDH (Paddenberg et al., 2003). ROS production follow-between mutations in SDH and the highly vascularized tumors
ing SDH inhibition has been reported previously to occur inwhich develop as a consequence of HIF-1 induction in the
C. elegans carrying a SDHC mutation, mev-1 (Senoo-Matsudaabsence of VHL mutations. These results show that succinate
et al., 2001). Interestingly, this mutation has no effect on succi-may function as an intracellular messenger between mitochon-
nate levels in the nematode, indicating that succinate was re-dria and the cytosol and has a profound effect on cytosolic
moved by oxidation to fumarate and that oxygen may haveenzymes (PHD) and consequently on nuclear events (gene ex-
been used as the final electron acceptor, hence generatingpression by HIF) (Figure 7). It is noteworthy that, in addition
superoxide ions (Senoo-Matsuda et al., 2001). This observationto the described SDH mutations in pheochromocytoma and
is not consistent with the data reported in the present study,paraganglioma, significant reduction in SDH expression has
and may suggest either that human and nematode SDH differalso been described in gastric and colorectal carcinoma (Ha-
in their ability to generate ROS, or that different mutations havebano et al., 2003), in particular during transition to the more
different outcomes. The observation that succinate level is ele-aggressive Dukes’ stage C colorectal cancer, as compared to
vated in tumors with SDH mutations (P. Rustin; personal com-the confined Dukes’ stage B tumors (Frederiksen et al., 2003).
munication) suggests that our model is more relevant for humanTherefore, it is plausible that the succinate signaling pathway
tumors.elucidated here plays a more general role in tumorigenesis, in
Succinate has been recently shown to be a ligand for a Gparticular in the transition to a more infiltrating form.
protein-coupled receptor, suggesting that succinate can alsoIt is frequently hypothesized in the literature that ROS gener-
be released from cells under some physiological/pathologicalation due to SDH mutations may mediate HIF-1 induction
circumstances (He et al., 2004). It is likely that succinate may(Baysal, 2003; Eng et al., 2003; Pollard et al., 2003; Rustin and
function as a physiological as well as a pathological intracellularRotig, 2002). However, to our knowledge, there are no published
messenger. For instance, physiological levels of nitric oxide (NO)data that actually show ROS generation by themutated or inhib-
can block the induction of HIF-1 under hypoxic conditionsited SDH inmammalian cells or human tumors. Indeed, although
by preventing oxygen consumption at cytochrome c oxidasewe found that hydrogen peroxide can induce HIF-1 levels as
(complex IV), hence allocating more oxygen for PHD activity inwas previously described (Chandel et al., 2000) (data not
shown), we observed neither ROS generation nor a shift to a the cytosol (Hagen et al., 2003). Under these conditions, SDH
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reaction specificity. The specific activity of TTFA-sensitive succinate-DCIPinhibition and succinate accumulation reverse this effect (data
oxidoreductase is reported as nmol/min/mg cell protein.not shown). This suggests a more complex mechanism for HIF
induction under hypoxic conditions involving oxygen, NO, and
Redox state analysis
succinate levels. Hence, different cells may have different For microscopic analysis of ROS generation, cells were transfected as indi-
thresholds and mechanisms of HIF activation. Moreover, unlike cated in the text and 30 hr later incubated with 10 M DHE (Molecular
pVHL, which regulates HIF-1 levels, succinatemay additionally Probes) for 30 min followed by fluorescent microscopic analysis.
For studying reduced and total glutathione levels, cell lysates wereregulate HIF activity by modulating another -ketoglutarate de-
prepared using a lysis buffer (Cell Signaling) freshly supplemented withpendent dioxygenase, FIH, thereby altering the ability of HIF-1
protease inhibitor cocktail for mammalian tissues (Sigma). Immediately fol-to bind the coactivator p300 (Hewitson et al., 2002; Lando et
lowing centrifugation to clear the lysates, aliquots of the supernatant were
al., 2002a, 2002b). Such a regulatory mechanism may dictate assayed for GSH in 25 mM KH2PO4 (pH 7.2) containing 20 M ThioGlo-1
the outcome (the pattern of gene expression) of HIF activity and (Calbiochem) and for total glutathione after adding 100 M NADPH and 3.5
U/ml glutathione reductase. Fluorescence intensities were monitored usingadd another level of complexity to this signaling pathway.
an excitation wavelength of 405 nm and emission wavelength of 485 nm
and were converted to GSH concentrations by comparison with standards.Experimental procedures
Succinic acid quantification by GCMSPlasmids
Cell extracts were prepared in 90% methanol, 10% acetic acid containingThe SDHD siRNA hairpins were cloned into pBABE-Puro LTR together
1 g/ml (D4)-succinic acid. Extracts were evaporated to dryness under nitro-with the U6 promoter, as previously described (Fox et al., 2003). A PCR-
gen at 60C and methylated by redissolving in 1% HCl in methanol for 10based strategy was employed using pEF6-hU6 as a template and primers
min at 60C. The extracts were redried and dissolved in hexane and 1 lcontaining SDHD DNA hairpin sequences (Di3  sense 5	-GGTCAGACCT
was injected into an Automass Multi GCMS system. The instrument wasGCTCATATCTCAGCA-3	; Di4  sense 5	-GGTGTGGAGTGCAGCACATA
fitted with a ZB-1 column (30 meters 
 0.32 mm id 
 1 m film), the ovenCAC-3	). scRNAi was cloned into pSuperRetro (OligoEngine) with the hairpin
was programmed as follows: 80C (5 min) then 10C/min to 170C, the headsequence, sense, 5	-GATACGGTAGGGCGACAA-3	.
pressure was 60 kPa. The mass spectrometer was operated in EI mode atpGL2/HRE-luciferase was generated by inserting 3 copies in tandem
70 eV and selected ion monitoring was carried out for ions at 119 and 91of the 24-mer oligonucleotide (5	-tgtcacgtcctgcacgactctagt) in front of a
amu (methyl ester of [D4]-succinic acid) and 115 and 87 amu (methyl esterminimal thymidine kinase promoter into pGL2-basic (Promega). The oligonu-
of succinic acid).cleotide contains 18 bp from PGK promoter including the HRE.
pRK5/HA-ODD was generated by cloning the human HIF-1 ODD do-
Immunostainingmain (amino acids 530–652) in frame into a vector containing HA-tag and
HEK293 cells plated on fibronectin-coated chamber slides were incubatedGal4 DNA binding domain. Then the entire cDNA was cloned into pRK5
in DMEM or DMEM supplemented with 20 mM DMS for 24 hr. The cells werevector.
fixed in formalin and permeabilized in a 0.05% saponin solution followed bypEGFP/ODD, the plasmid encoding the GFP-ODD domain fusion pro-
incubation in 0.3% hydrogen peroxide. Subcellular localization of HIF-1tein, was generated as follows: A PCR fragment of hHIF-1 ODD domain
was monitored by staining with a monoclonal anti-HIF-1 antibody (BDwas generated using PRK5/HA-ODD as a template and ligated in frame into
Biosciences Pharmingen) followed by peroxidase-conjugated secondary an-pEGFP-C1 (Clontech).
tibody (Immpress reagent, Vector Laboratories) and diaminobenzidine (DAB)
substrate to detect the signal. Cells were counterstained with hematoxylin.RT-PCR analysis
Cells were treated as indicated in the text and total RNA was isolated using
Protein analysesRNA-B solution (Biogenesis) according to the manufacturer’s instructions.
For HIF-1 immunoblot, cells were extracted in Laemmli sample buffer andSemiquantitative reverse transcription was performed using a GeneAmp
for all other analyses in Tris lysis buffer (50 mM Tris [pH 8.0], 150 mMRNAPCRkit (AppliedBiosystems). RNA (1g) was reverse-transcribed using
NaCl, 0.5% NP40, supplemented with “complete” protease inhibitor cocktailrandom hexamers and PCR was carried out with the following conditions: 2
[Roche] and 100 M ALLN). Following SDS-PAGE, proteins were blottedmin at 95C, followed by 30 cycles of 30 s at 95C, 30 s at 57C, 1 min at
onto nitrocellulose and analyzed with the following antibodies: anti-HIF-172C, then 15 min at 72C. Primers used for amplification were: SDHD
(BD Biosciences), anti-HA (Roche), anti-GFP (BD Biosciences), or anti-actinforward 5	-ATGGCGGTTCTCTGGAGGCTG-3	; reverse 5	-GAGCTTCCAC
(Sigma). Immunoprecipitation for HA-pVHL was carried out using an anti-
AGCATGGCAAC-3	, VEGF forward 5	-ATGAACTTTCTGCTGTCTTGGGT-3	;
HA antibody (Roche) and protein G Sepharose beads (Phramacia) in Tris
reverse 5	-TCACCGCCTCGGCTTGTCACA-3	, actin forward 5	-TCCATCA
lysis buffer. Proteins were eluted by incubating the beads with 1 mg/ml HA-
TGAAGTGTGACGT-3	; reverse 5	-TACTCCTGCTTGCTGATCCAC-3	.
peptide in TBS for 15 min at 37C. Eluates were immediately subjected to
fluorometric analysis in a 96-well plate fluorometer (Molecular Devices) to
In vitro PHD activity determine GFP or GFP-ODD levels.
HA-ODD was in vitro translated (IVT) using wheat germ extract (Promega), Preparation of HA-pVHL protein as a probe for far Western blot analysis
and 4 l aliquots of the IVT reaction were incubated with 50 l of HEK293 was carried out as follows: pRc-CMV/HA-pVHLwas transfected into HEK293
cellular extracts (20 mM Tris [pH 7.4], 5 mM KCl, 1.5 mM MgCl2, 1 mM DTT, cells, and 30 hr later, HA-pVHL protein was immunopurified from the cell
supplemented with “complete” protease inhibitor cocktail [Roche] and 100 extract on an anti-HA matrix (Roche) according to manufacturer’s instruc-
M ALLN). The reaction was carried out for 15 min at 37C in the presence tions. Following elution of the protein with HA peptide, the eluate was dia-
of 5 mM ascorbate and 100 M FeCl2 with either 5 mM DFO or the indicated lyzed overnight in TBS and HA-pVHL levels were assessed by SDS-PAGE
amounts of succinate. Reactionswere terminated by adding Laemmli sample followed by Coomassie blue staining and Western blot analysis.
buffer and immediate boiling. Following SDS-PAGE, samples were analyzed For far Western blot analysis, protein extracts from GFP-ODD-express-
by Western blot using an anti-HA antibody. ing cells were blotted onto nitrocellulose membrane and blocked in 5%
nonfat dry milk in TBST for 2 hr. Following several washes with TBST,
SDH activity (complex II; succinate-DCIP oxidoreductase) HA-pVHL protein in TBST/milk (1 g/ml) was added to the nitrocellulose
Cells were lysed with 0.1% v/v Triton X100 in an assay buffer composed of membrane and incubated over night at 4C, followed by several washes
25 mM KHPO4 (pH 7.4), 20 mM succinate, 50 M decylubiquinone, 5 M with TBST and detection with an anti-HA antibody.
rotenone, 2 Mantimycin A, and 10mMNaN3. Following a 15 min incubation
at room temperature, the baseline absorbance at 600 nm was recorded and Acknowledgments
the reaction initiated by adding 50 MDCIP (  21mM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1). The change
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